Vanda Pharmaceuticals Inc (NASDAQ: VNDA) closed the day trading at $3.87 up 1.31% from the previous closing price of $3.82. In other words, the price has increased by $+0.0500 from its previous closing price. On the day, 1156952 shares were traded.
Ratios:
For a better understanding of VNDA, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 0.57 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 17.93. For the most recent quarter (mrq), Quick Ratio is recorded 4.92 and its Current Ratio is at 4.94. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on February 25, 2022, Downgraded its rating to Hold and sets its target price to $12 from $24 previously.
On May 12, 2021, BofA Securities started tracking the stock assigning a Buy rating and target price of $22.
Citigroup Downgraded its Buy to Neutral on January 14, 2021, while the target price for the stock was maintained at $14.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 05 ’24 when Polymeropoulos Mihael Hristos sold 24,288 shares for $4.13 per share. The transaction valued at 100,273 led to the insider holds 1,871,730 shares of the business.
Wijkstrom Joakim sold 9,229 shares of VNDA for $38,830 on Mar 05 ’24. The SVP, Chief Marketing Officer now owns 129,789 shares after completing the transaction at $4.21 per share. On Mar 05 ’24, another insider, Moran Kevin Patrick, who serves as the SVP, CFO & Treasurer of the company, sold 8,902 shares for $4.20 each. As a result, the insider received 37,411 and left with 231,014 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VNDA now has a Market Capitalization of 222.67M and an Enterprise Value of -156.19M. As of this moment, Vanda’s Price-to-Earnings (P/E) ratio for their current fiscal year is 88.56. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.45. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.16 while its Price-to-Book (P/B) ratio in mrq is 0.41. Its current Enterprise Value per Revenue stands at -0.81 whereas that against EBITDA is 14.27.
Stock Price History:
Over the past 52 weeks, VNDA has reached a high of $7.00, while it has fallen to a 52-week low of $3.30. The 50-Day Moving Average of the stock is 4.0554, while the 200-Day Moving Average is calculated to be 4.8239.
Shares Statistics:
Over the past 3-months, VNDA traded about 1.01M shares per day on average, while over the past 10 days, VNDA traded about 1.07M shares per day. A total of 57.53M shares are outstanding, with a floating share count of 54.39M. Insiders hold about 5.47% of the company’s shares, while institutions hold 89.56% stake in the company. Shares short for VNDA as of Feb 15, 2024 were 2.96M with a Short Ratio of 2.92, compared to 1.75M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 5.14% and a Short% of Float of 6.49%.
Earnings Estimates
Current recommendations for the stock of the company come from 1 analysts. On average, analysts expect EPS of $0.05 for the current quarter, with a high estimate of $0.05 and a low estimate of $0.05, while EPS last year was $0.12. The consensus estimate for the next quarter is $0.02, with high estimates of $0.02 and low estimates of $0.02.
Analysts are recommending an EPS of between $0.01 and $0.01 for the fiscal current year, implying an average EPS of $0.01. EPS for the following year is -$0.48, with 1 analysts recommending between -$0.48 and -$0.48.
Revenue Estimates
A total of 1 analysts have provided revenue estimates for VNDA’s current fiscal year. The highest revenue estimate was $188M, while the lowest revenue estimate was $188M, resulting in an average revenue estimate of $188M. In the same quarter a year ago, actual revenue was $192.64M, down -2.40% from the average estimate. Based on 1 analysts’ estimates, the company’s revenue will be $175.3M in the next fiscal year. The high estimate is $175.3M and the low estimate is $175.3M. The average revenue growth estimate for next year is down -6.80% from the average revenue estimate for this year.
